Angiolutions

Angiolutions is a Germany-based medtech company dedicated to developing innovative therapeutic devices for vascular diseases, with a strong emphasis on abdominal aortic aneurysms (AAAs). Founded by Dr. Uwe Raaz and Dr. Isabel N. Schellinger, the company combines biomechanical, biological, and molecular research with traditional engineering to create effective device-based therapies. The flagship product is a minimally invasive medical device designed to treat small AAAs. This unique device absorbs the aortic pulse waves generated by each heartbeat, which contribute to the growth of AAAs. By shielding the aneurysm from these pulse waves, the device aims to halt aneurysm progression and prevent potentially life-threatening ruptures. Angiolutions is focused on advancing its research and development efforts, supported by seed financing from various investors.

• Employees7